| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ErbB-3 class receptor binding | 4.46e-05 | 6 | 35 | 2 | GO:0043125 | |
| GeneOntologyMolecularFunction | RS domain binding | 8.30e-05 | 8 | 35 | 2 | GO:0050733 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 6.95e-04 | 875 | 35 | 7 | GO:0019904 | |
| GeneOntologyBiologicalProcess | RNA splicing | 1.80e-04 | 502 | 35 | 6 | GO:0008380 | |
| GeneOntologyBiologicalProcess | ERBB2-ERBB3 signaling pathway | 2.16e-04 | 13 | 35 | 2 | GO:0038133 | |
| GeneOntologyBiologicalProcess | ERBB3 signaling pathway | 2.51e-04 | 14 | 35 | 2 | GO:0038129 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 3.24e-04 | 358 | 35 | 5 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 3.24e-04 | 358 | 35 | 5 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 3.41e-04 | 362 | 35 | 5 | GO:0000375 | |
| GeneOntologyCellularComponent | nuclear speck | 5.02e-06 | 431 | 34 | 7 | GO:0016607 | |
| GeneOntologyCellularComponent | nuclear body | 7.84e-05 | 903 | 34 | 8 | GO:0016604 | |
| GeneOntologyCellularComponent | cell-cell junction | 3.41e-04 | 591 | 34 | 6 | GO:0005911 | |
| GeneOntologyCellularComponent | nuclear lamina | 3.44e-04 | 17 | 34 | 2 | GO:0005652 | |
| GeneOntologyCellularComponent | adherens junction | 3.76e-04 | 212 | 34 | 4 | GO:0005912 | |
| GeneOntologyCellularComponent | apicolateral plasma membrane | 9.45e-04 | 28 | 34 | 2 | GO:0016327 | |
| GeneOntologyCellularComponent | bicellular tight junction | 1.25e-03 | 131 | 34 | 3 | GO:0005923 | |
| GeneOntologyCellularComponent | tight junction | 1.48e-03 | 139 | 34 | 3 | GO:0070160 | |
| GeneOntologyCellularComponent | apical junction complex | 2.13e-03 | 158 | 34 | 3 | GO:0043296 | |
| Domain | SynMuv_product | 3.22e-06 | 2 | 34 | 2 | PF06047 | |
| Domain | NKAP/UPF0396 | 3.22e-06 | 2 | 34 | 2 | IPR009269 | |
| Domain | GAR | 4.80e-05 | 6 | 34 | 2 | PS51460 | |
| Domain | - | 4.80e-05 | 6 | 34 | 2 | 3.30.920.20 | |
| Domain | - | 4.80e-05 | 6 | 34 | 2 | 3.90.1290.10 | |
| Domain | GAS_dom | 4.80e-05 | 6 | 34 | 2 | IPR003108 | |
| Domain | GAS2 | 4.80e-05 | 6 | 34 | 2 | PF02187 | |
| Domain | GAS2 | 4.80e-05 | 6 | 34 | 2 | SM00243 | |
| Domain | Plectin_repeat | 6.72e-05 | 7 | 34 | 2 | IPR001101 | |
| Domain | Plectin | 6.72e-05 | 7 | 34 | 2 | PF00681 | |
| Domain | PLEC | 6.72e-05 | 7 | 34 | 2 | SM00250 | |
| Domain | Actinin_actin-bd_CS | 7.95e-04 | 23 | 34 | 2 | IPR001589 | |
| Domain | G_patch | 7.95e-04 | 23 | 34 | 2 | SM00443 | |
| Domain | G_patch_dom | 7.95e-04 | 23 | 34 | 2 | IPR000467 | |
| Domain | G-patch | 7.95e-04 | 23 | 34 | 2 | PF01585 | |
| Domain | ACTININ_2 | 7.95e-04 | 23 | 34 | 2 | PS00020 | |
| Domain | ACTININ_1 | 7.95e-04 | 23 | 34 | 2 | PS00019 | |
| Domain | Spectrin | 7.95e-04 | 23 | 34 | 2 | PF00435 | |
| Domain | G_PATCH | 7.95e-04 | 23 | 34 | 2 | PS50174 | |
| Domain | GUANYLATE_KINASE_2 | 7.95e-04 | 23 | 34 | 2 | PS50052 | |
| Domain | GUANYLATE_KINASE_1 | 7.95e-04 | 23 | 34 | 2 | PS00856 | |
| Domain | Guanylate_kin | 1.02e-03 | 26 | 34 | 2 | PF00625 | |
| Domain | GK/Ca_channel_bsu | 1.02e-03 | 26 | 34 | 2 | IPR008145 | |
| Domain | Guanylate_kin-like_dom | 1.02e-03 | 26 | 34 | 2 | IPR008144 | |
| Domain | GuKc | 1.02e-03 | 26 | 34 | 2 | SM00072 | |
| Domain | Spectrin_repeat | 1.27e-03 | 29 | 34 | 2 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 1.54e-03 | 32 | 34 | 2 | IPR018159 | |
| Domain | SPEC | 1.54e-03 | 32 | 34 | 2 | SM00150 | |
| Domain | CH | 6.23e-03 | 65 | 34 | 2 | SM00033 | |
| Domain | SH3 | 7.01e-03 | 216 | 34 | 3 | PS50002 | |
| Domain | CH | 7.19e-03 | 70 | 34 | 2 | PF00307 | |
| Domain | SH3_domain | 7.37e-03 | 220 | 34 | 3 | IPR001452 | |
| Domain | - | 7.39e-03 | 71 | 34 | 2 | 1.10.418.10 | |
| Domain | CH | 7.80e-03 | 73 | 34 | 2 | PS50021 | |
| Domain | CH-domain | 8.21e-03 | 75 | 34 | 2 | IPR001715 | |
| Domain | EF-hand_7 | 1.04e-02 | 85 | 34 | 2 | PF13499 | |
| Pathway | REACTOME_MRNA_SPLICING | 1.86e-07 | 212 | 29 | 7 | M14033 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 1.30e-06 | 283 | 29 | 7 | M13087 | |
| Pathway | REACTOME_GRB7_EVENTS_IN_ERBB2_SIGNALING | 4.07e-05 | 5 | 29 | 2 | M26937 | |
| Pathway | REACTOME_MRNA_SPLICING | 5.04e-05 | 201 | 29 | 5 | MM15411 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 2.28e-04 | 277 | 29 | 5 | MM15414 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | 3.14e-04 | 13 | 29 | 2 | M549 | |
| Pathway | REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING | 3.14e-04 | 13 | 29 | 2 | M27729 | |
| Pathway | PID_ERBB_NETWORK_PATHWAY | 4.22e-04 | 15 | 29 | 2 | M201 | |
| Pathway | REACTOME_ERBB2_REGULATES_CELL_MOTILITY | 4.22e-04 | 15 | 29 | 2 | M27608 | |
| Pathway | REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING | 4.82e-04 | 16 | 29 | 2 | M570 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 5.29e-04 | 724 | 29 | 7 | M16843 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING | 9.20e-04 | 22 | 29 | 2 | M26929 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 9.84e-04 | 96 | 29 | 3 | MM14592 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2_IN_CANCER | 1.29e-03 | 26 | 29 | 2 | M29535 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING | 1.60e-03 | 29 | 29 | 2 | M27756 | |
| Pathway | PID_NEPHRIN_NEPH1_PATHWAY | 1.83e-03 | 31 | 29 | 2 | M193 | |
| Pathway | KEGG_SPLICEOSOME | 2.20e-03 | 127 | 29 | 3 | M2044 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | MACF1 PPIG NKAP LBR SRSF1 CHERP RPP25L SRRM2 BCLAF1 SRSF8 SON | 3.47e-10 | 807 | 36 | 11 | 22681889 |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | 1.51e-09 | 695 | 36 | 10 | 23602568 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 2.93e-09 | 361 | 36 | 8 | 26167880 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 4.18e-09 | 1024 | 36 | 11 | 24711643 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 7.40e-09 | 1082 | 36 | 11 | 38697112 | |
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | 8.13e-09 | 259 | 36 | 7 | 30404004 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 3.06e-08 | 954 | 36 | 10 | 36373674 | |
| Pubmed | 4.32e-08 | 731 | 36 | 9 | 29298432 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 7.46e-08 | 358 | 36 | 7 | 32460013 | |
| Pubmed | PPIG NKAP LBR SRSF1 CTNND1 RPP25L CWC25 TJP1 BCLAF1 SRSF8 SON | 8.31e-08 | 1371 | 36 | 11 | 36244648 | |
| Pubmed | 2.37e-07 | 255 | 36 | 6 | 15324660 | ||
| Pubmed | 3.05e-07 | 660 | 36 | 8 | 32780723 | ||
| Pubmed | 5.47e-07 | 713 | 36 | 8 | 29802200 | ||
| Pubmed | p120 catenin is required for normal renal tubulogenesis and glomerulogenesis. | 9.76e-07 | 19 | 36 | 3 | 21521738 | |
| Pubmed | 9.76e-07 | 19 | 36 | 3 | 25263594 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 17509776 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 11002341 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 33095160 | ||
| Pubmed | Identification of mNET1 as a candidate ligand for the first PDZ domain of MAGI-1. | 1.04e-06 | 2 | 36 | 2 | 11350080 | |
| Pubmed | 1.43e-06 | 347 | 36 | 6 | 17114649 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 1.60e-06 | 565 | 36 | 7 | 25468996 | |
| Pubmed | Dynamic protein-protein interaction wiring of the human spliceosome. | 1.81e-06 | 197 | 36 | 5 | 22365833 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 2.24e-06 | 861 | 36 | 8 | 36931259 | |
| Pubmed | Expression of the mouse Macf2 gene during inner ear development. | 3.12e-06 | 3 | 36 | 2 | 12399109 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 21732359 | ||
| Pubmed | SON is an essential RNA splicing factor promoting ErbB2 and ErbB3 expression in breast cancer. | 3.12e-06 | 3 | 36 | 2 | 39313574 | |
| Pubmed | ErbB tyrosine kinases and the two neuregulin families constitute a ligand-receptor network. | 3.12e-06 | 3 | 36 | 2 | 9742126 | |
| Pubmed | 3.74e-06 | 1247 | 36 | 9 | 27684187 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 4.08e-06 | 934 | 36 | 8 | 33916271 | |
| Pubmed | 4.14e-06 | 653 | 36 | 7 | 22586326 | ||
| Pubmed | 4.23e-06 | 655 | 36 | 7 | 35819319 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 4.58e-06 | 949 | 36 | 8 | 36574265 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | 4.67e-06 | 665 | 36 | 7 | 30457570 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 5.04e-06 | 1294 | 36 | 9 | 30804502 | |
| Pubmed | 5.10e-06 | 963 | 36 | 8 | 28671696 | ||
| Pubmed | 5.15e-06 | 244 | 36 | 5 | 29884807 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 5.85e-06 | 1318 | 36 | 9 | 30463901 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 6.20e-06 | 989 | 36 | 8 | 36424410 | |
| Pubmed | Early glomerular filtration defect and severe renal disease in podocin-deficient mice. | 6.24e-06 | 4 | 36 | 2 | 14701729 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 19586902 | ||
| Pubmed | Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases. | 6.24e-06 | 4 | 36 | 2 | 9168115 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 8954775 | ||
| Pubmed | Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase. | 6.50e-06 | 256 | 36 | 5 | 32698014 | |
| Pubmed | 7.02e-06 | 708 | 36 | 7 | 39231216 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 7.23e-06 | 1353 | 36 | 9 | 29467282 | |
| Pubmed | 9.03e-06 | 274 | 36 | 5 | 34244482 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 38311119 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 19332538 | ||
| Pubmed | Ligands for ErbB-family receptors encoded by a neuregulin-like gene. | 1.04e-05 | 5 | 36 | 2 | 9168114 | |
| Pubmed | Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements. | 1.56e-05 | 6 | 36 | 2 | 17361132 | |
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 26076477 | ||
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 15358134 | ||
| Pubmed | 1.60e-05 | 47 | 36 | 3 | 32253237 | ||
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | 1.77e-05 | 315 | 36 | 5 | 26777405 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 1.91e-05 | 1155 | 36 | 8 | 20360068 | |
| Pubmed | 2.05e-05 | 156 | 36 | 4 | 22952844 | ||
| Pubmed | The P-body component USP52/PAN2 is a novel regulator of HIF1A mRNA stability. | 2.15e-05 | 328 | 36 | 5 | 23398456 | |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 2.21e-05 | 330 | 36 | 5 | 33301849 | |
| Pubmed | 2.23e-05 | 847 | 36 | 7 | 35850772 | ||
| Pubmed | The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus. | 2.81e-05 | 169 | 36 | 4 | 23084401 | |
| Pubmed | 2.91e-05 | 8 | 36 | 2 | 15306553 | ||
| Pubmed | 2.91e-05 | 8 | 36 | 2 | 22662192 | ||
| Pubmed | Patched Receptors Sense, Interpret, and Establish an Epidermal Hedgehog Signaling Gradient. | 2.91e-05 | 8 | 36 | 2 | 27498049 | |
| Pubmed | 2.91e-05 | 8 | 36 | 2 | 16488402 | ||
| Pubmed | 2.91e-05 | 8 | 36 | 2 | 17130295 | ||
| Pubmed | NEPH1 defines a novel family of podocin interacting proteins. | 2.91e-05 | 8 | 36 | 2 | 12424224 | |
| Pubmed | SR protein-specific kinase 1 is highly expressed in testis and phosphorylates protamine 1. | 2.91e-05 | 8 | 36 | 2 | 10390541 | |
| Pubmed | Dynamic expression of Erbb pathway members during early mammary gland morphogenesis. | 2.91e-05 | 8 | 36 | 2 | 17960183 | |
| Pubmed | Global phosphoproteome of HT-29 human colon adenocarcinoma cells. | 3.18e-05 | 59 | 36 | 3 | 16083285 | |
| Pubmed | 3.25e-05 | 601 | 36 | 6 | 33658012 | ||
| Pubmed | 3.35e-05 | 360 | 36 | 5 | 33111431 | ||
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | 3.44e-05 | 607 | 36 | 6 | 39147351 | |
| Pubmed | 3.73e-05 | 9 | 36 | 2 | 19170756 | ||
| Pubmed | 3.73e-05 | 9 | 36 | 2 | 17938206 | ||
| Pubmed | Analysis of the Histone H3.1 Interactome: A Suitable Chaperone for the Right Event. | 3.75e-05 | 182 | 36 | 4 | 26527279 | |
| Pubmed | 4.25e-05 | 188 | 36 | 4 | 29721183 | ||
| Pubmed | 4.66e-05 | 10 | 36 | 2 | 19071123 | ||
| Pubmed | 4.66e-05 | 10 | 36 | 2 | 22538088 | ||
| Pubmed | The role of microtubule actin cross-linking factor 1 (MACF1) in the Wnt signaling pathway. | 5.70e-05 | 11 | 36 | 2 | 16815997 | |
| Pubmed | 5.70e-05 | 11 | 36 | 2 | 12642503 | ||
| Pubmed | 5.70e-05 | 11 | 36 | 2 | 22479204 | ||
| Pubmed | RNF125 attenuates hepatocellular carcinoma progression by downregulating SRSF1-ERK pathway. | 5.70e-05 | 11 | 36 | 2 | 37142680 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 6.35e-05 | 678 | 36 | 6 | 30209976 | |
| Pubmed | 6.80e-05 | 76 | 36 | 3 | 27542412 | ||
| Pubmed | Nephrin is involved in podocyte maturation but not survival during glomerular development. | 6.83e-05 | 12 | 36 | 2 | 18046313 | |
| Pubmed | A novel SR-related protein is required for the second step of Pre-mRNA splicing. | 6.83e-05 | 12 | 36 | 2 | 15798186 | |
| Pubmed | 7.16e-05 | 215 | 36 | 4 | 35973513 | ||
| Pubmed | MAP4K Interactome Reveals STRN4 as a Key STRIPAK Complex Component in Hippo Pathway Regulation. | 7.29e-05 | 216 | 36 | 4 | 32640226 | |
| Pubmed | 7.92e-05 | 80 | 36 | 3 | 25662211 | ||
| Pubmed | 8.07e-05 | 13 | 36 | 2 | 28482867 | ||
| Pubmed | Centrosomal protein CP110 controls maturation of the mother centriole during cilia biogenesis. | 8.07e-05 | 13 | 36 | 2 | 26965371 | |
| Pubmed | 8.07e-05 | 13 | 36 | 2 | 21406566 | ||
| Pubmed | A rational nomenclature for serine/arginine-rich protein splicing factors (SR proteins). | 8.07e-05 | 13 | 36 | 2 | 20516191 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 8.45e-05 | 1425 | 36 | 8 | 30948266 | |
| Pubmed | 8.70e-05 | 1431 | 36 | 8 | 37142655 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 9.12e-05 | 724 | 36 | 6 | 36232890 | |
| Pubmed | Patched1 is required in neural crest cells for the prevention of orofacial clefts. | 9.41e-05 | 14 | 36 | 2 | 23900075 | |
| Pubmed | The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. | 9.41e-05 | 14 | 36 | 2 | 22144466 | |
| Pubmed | 9.41e-05 | 14 | 36 | 2 | 23789091 | ||
| Pubmed | 9.93e-05 | 234 | 36 | 4 | 36243803 | ||
| Interaction | SRPK2 interactions | MACF1 MCM4 PPIG ERBB3 NKAP LBR SRSF1 CHERP SRRM2 BCLAF1 SRSF8 SON NSMCE4A | 9.42e-11 | 717 | 35 | 13 | int:SRPK2 |
| Interaction | SRPK1 interactions | MCM4 PPIG NKAP LBR SRSF1 CHERP SRRM2 BCLAF1 SRSF8 SON NSMCE4A | 2.91e-10 | 477 | 35 | 11 | int:SRPK1 |
| Interaction | CLK3 interactions | 3.24e-09 | 220 | 35 | 8 | int:CLK3 | |
| Interaction | LUC7L interactions | 6.85e-09 | 242 | 35 | 8 | int:LUC7L | |
| Interaction | YWHAG interactions | MAGI1 MACF1 PPIG NKAP LBR SRSF1 DST CTNND1 SRRM2 NET1 TJP1 BCLAF1 SRSF8 SON | 7.69e-09 | 1248 | 35 | 14 | int:YWHAG |
| Interaction | NKAPD1 interactions | 1.02e-08 | 161 | 35 | 7 | int:NKAPD1 | |
| Interaction | SNIP1 interactions | 4.53e-07 | 417 | 35 | 8 | int:SNIP1 | |
| Interaction | DHX8 interactions | 5.93e-07 | 292 | 35 | 7 | int:DHX8 | |
| Interaction | MECP2 interactions | MACF1 PPIG LBR SRSF1 DST CHERP SRRM2 NKAPL TJP1 BCLAF1 SRSF8 SON | 9.21e-07 | 1287 | 35 | 12 | int:MECP2 |
| Interaction | SNRPB interactions | 2.27e-06 | 517 | 35 | 8 | int:SNRPB | |
| Interaction | CIT interactions | MAGI1 MACF1 MCM4 SRSF1 CHERP CTNND1 SRRM2 NKAPL TJP1 BCLAF1 SRSF8 SON | 3.23e-06 | 1450 | 35 | 12 | int:CIT |
| Interaction | LARP4B interactions | 3.26e-06 | 240 | 35 | 6 | int:LARP4B | |
| Interaction | PABPC5 interactions | 4.43e-06 | 142 | 35 | 5 | int:PABPC5 | |
| Interaction | SMC5 interactions | 5.10e-06 | 1000 | 35 | 10 | int:SMC5 | |
| Interaction | SRSF7 interactions | 7.13e-06 | 425 | 35 | 7 | int:SRSF7 | |
| Interaction | KIF20A interactions | 7.99e-06 | 1052 | 35 | 10 | int:KIF20A | |
| Interaction | SNRPC interactions | 8.93e-06 | 440 | 35 | 7 | int:SNRPC | |
| Interaction | CDC5L interactions | 1.11e-05 | 855 | 35 | 9 | int:CDC5L | |
| Interaction | RAD18 interactions | 1.14e-05 | 457 | 35 | 7 | int:RAD18 | |
| Interaction | SRSF4 interactions | 1.17e-05 | 300 | 35 | 6 | int:SRSF4 | |
| Interaction | YWHAH interactions | 1.20e-05 | 1102 | 35 | 10 | int:YWHAH | |
| Interaction | MYCN interactions | TGM1 PPIG NKAP LBR SRSF1 CHERP RPP25L CWC25 SRRM2 BCLAF1 SON | 1.28e-05 | 1373 | 35 | 11 | int:MYCN |
| Interaction | SAP18 interactions | 1.28e-05 | 305 | 35 | 6 | int:SAP18 | |
| Interaction | ZC3H18 interactions | 1.37e-05 | 877 | 35 | 9 | int:ZC3H18 | |
| Interaction | ECT2 interactions | 1.49e-05 | 887 | 35 | 9 | int:ECT2 | |
| Interaction | TTC14 interactions | 1.53e-05 | 28 | 35 | 3 | int:TTC14 | |
| Interaction | DDX23 interactions | 1.57e-05 | 480 | 35 | 7 | int:DDX23 | |
| Interaction | SNRPA interactions | 1.61e-05 | 482 | 35 | 7 | int:SNRPA | |
| Interaction | OBSL1 interactions | 1.71e-05 | 902 | 35 | 9 | int:OBSL1 | |
| Interaction | NUPR1 interactions | 1.75e-05 | 683 | 35 | 8 | int:NUPR1 | |
| Interaction | MDK interactions | 1.83e-05 | 91 | 35 | 4 | int:MDK | |
| Interaction | CLK2 interactions | 2.07e-05 | 195 | 35 | 5 | int:CLK2 | |
| Interaction | EED interactions | MACF1 MCM4 LBR SRSF1 CTNND1 CROCC SRRM2 TJP1 BCLAF1 SRSF8 SON | 2.07e-05 | 1445 | 35 | 11 | int:EED |
| Interaction | SRSF6 interactions | 2.12e-05 | 503 | 35 | 7 | int:SRSF6 | |
| Interaction | SRSF11 interactions | 2.51e-05 | 203 | 35 | 5 | int:SRSF11 | |
| Interaction | AKAP17A interactions | 2.55e-05 | 99 | 35 | 4 | int:AKAP17A | |
| Interaction | CPSF6 interactions | 2.83e-05 | 526 | 35 | 7 | int:CPSF6 | |
| Interaction | LUC7L2 interactions | 2.93e-05 | 353 | 35 | 6 | int:LUC7L2 | |
| Interaction | CLK1 interactions | 3.60e-05 | 219 | 35 | 5 | int:CLK1 | |
| Interaction | KIF23 interactions | 4.90e-05 | 1031 | 35 | 9 | int:KIF23 | |
| Interaction | U2AF1 interactions | 5.46e-05 | 239 | 35 | 5 | int:U2AF1 | |
| Interaction | NET1 interactions | 6.05e-05 | 44 | 35 | 3 | int:NET1 | |
| Interaction | NRG2 interactions | 6.12e-05 | 7 | 35 | 2 | int:NRG2 | |
| Interaction | NXF1 interactions | 6.66e-05 | 1345 | 35 | 10 | int:NXF1 | |
| Interaction | PAGE4 interactions | 7.15e-05 | 253 | 35 | 5 | int:PAGE4 | |
| Interaction | NKAP interactions | 7.87e-05 | 132 | 35 | 4 | int:NKAP | |
| Interaction | RNPS1 interactions | 8.21e-05 | 425 | 35 | 6 | int:RNPS1 | |
| Interaction | PRPF40A interactions | 1.07e-04 | 446 | 35 | 6 | int:PRPF40A | |
| Interaction | U2AF2 interactions | 1.09e-04 | 651 | 35 | 7 | int:U2AF2 | |
| Interaction | BMI1 interactions | 1.17e-04 | 659 | 35 | 7 | int:BMI1 | |
| Interaction | GSK3A interactions | 1.33e-04 | 464 | 35 | 6 | int:GSK3A | |
| Interaction | SF3A1 interactions | 1.44e-04 | 471 | 35 | 6 | int:SF3A1 | |
| Interaction | SRSF5 interactions | 1.49e-04 | 474 | 35 | 6 | int:SRSF5 | |
| Interaction | SFN interactions | 1.59e-04 | 692 | 35 | 7 | int:SFN | |
| Interaction | RNF113A interactions | 1.59e-04 | 692 | 35 | 7 | int:RNF113A | |
| Interaction | LYN interactions | 2.02e-04 | 720 | 35 | 7 | int:LYN | |
| Interaction | SREK1IP1 interactions | 2.04e-04 | 66 | 35 | 3 | int:SREK1IP1 | |
| Interaction | PRC1 interactions | 2.11e-04 | 973 | 35 | 8 | int:PRC1 | |
| Interaction | GLDC interactions | 2.18e-04 | 321 | 35 | 5 | int:GLDC | |
| Interaction | NAA40 interactions | 2.18e-04 | 978 | 35 | 8 | int:NAA40 | |
| Interaction | VSTM4 interactions | 2.26e-04 | 13 | 35 | 2 | int:VSTM4 | |
| Interaction | SNRNP70 interactions | 2.27e-04 | 984 | 35 | 8 | int:SNRNP70 | |
| Interaction | SIRT7 interactions | 2.48e-04 | 744 | 35 | 7 | int:SIRT7 | |
| Interaction | AFDN interactions | 2.58e-04 | 333 | 35 | 5 | int:AFDN | |
| Interaction | GRK5 interactions | 2.71e-04 | 182 | 35 | 4 | int:GRK5 | |
| Interaction | YWHAB interactions | 2.79e-04 | 1014 | 35 | 8 | int:YWHAB | |
| Interaction | CDH1 interactions | 3.00e-04 | 768 | 35 | 7 | int:CDH1 | |
| Interaction | RBM39 interactions | 3.35e-04 | 1042 | 35 | 8 | int:RBM39 | |
| Interaction | EZR interactions | 3.42e-04 | 553 | 35 | 6 | int:EZR | |
| Interaction | MYCBP2 interactions | 3.47e-04 | 355 | 35 | 5 | int:MYCBP2 | |
| Interaction | ATOH1 interactions | 3.60e-04 | 80 | 35 | 3 | int:ATOH1 | |
| Interaction | MECOM interactions | 3.60e-04 | 358 | 35 | 5 | int:MECOM | |
| Interaction | SF3B1 interactions | 4.06e-04 | 571 | 35 | 6 | int:SF3B1 | |
| Interaction | CXADR interactions | 4.14e-04 | 369 | 35 | 5 | int:CXADR | |
| Interaction | PUF60 interactions | 4.14e-04 | 369 | 35 | 5 | int:PUF60 | |
| Interaction | ACTA1 interactions | 4.24e-04 | 371 | 35 | 5 | int:ACTA1 | |
| Interaction | JMJD6 interactions | 4.25e-04 | 205 | 35 | 4 | int:JMJD6 | |
| Interaction | ILF2 interactions | 4.83e-04 | 590 | 35 | 6 | int:ILF2 | |
| Interaction | SNRPF interactions | 5.02e-04 | 385 | 35 | 5 | int:SNRPF | |
| Interaction | NR2C2 interactions | 5.05e-04 | 1403 | 35 | 9 | int:NR2C2 | |
| Interaction | PIP4K2A interactions | 5.18e-04 | 216 | 35 | 4 | int:PIP4K2A | |
| Interaction | RBBP6 interactions | 5.18e-04 | 216 | 35 | 4 | int:RBBP6 | |
| Interaction | CUL7 interactions | 5.34e-04 | 845 | 35 | 7 | int:CUL7 | |
| Interaction | PAN2 interactions | 5.77e-04 | 397 | 35 | 5 | int:PAN2 | |
| Interaction | ZMYND11 interactions | 5.77e-04 | 94 | 35 | 3 | int:ZMYND11 | |
| Interaction | ARRDC3 interactions | 5.94e-04 | 224 | 35 | 4 | int:ARRDC3 | |
| Interaction | H3C6 interactions | 6.14e-04 | 226 | 35 | 4 | int:H3C6 | |
| Interaction | AIRE interactions | 6.33e-04 | 97 | 35 | 3 | int:AIRE | |
| Interaction | MAST1 interactions | 6.34e-04 | 228 | 35 | 4 | int:MAST1 | |
| Interaction | KCNA3 interactions | 6.40e-04 | 871 | 35 | 7 | int:KCNA3 | |
| Interaction | MAP4K2 interactions | 6.52e-04 | 98 | 35 | 3 | int:MAP4K2 | |
| Interaction | LUZP4 interactions | 6.71e-04 | 99 | 35 | 3 | int:LUZP4 | |
| Interaction | RBMX2 interactions | 7.12e-04 | 101 | 35 | 3 | int:RBMX2 | |
| Interaction | ZCCHC10 interactions | 7.22e-04 | 236 | 35 | 4 | int:ZCCHC10 | |
| Interaction | NKAPL interactions | 7.90e-04 | 24 | 35 | 2 | int:NKAPL | |
| Interaction | CHCHD1 interactions | 8.05e-04 | 243 | 35 | 4 | int:CHCHD1 | |
| Interaction | GSPT2 interactions | 8.42e-04 | 107 | 35 | 3 | int:GSPT2 | |
| Interaction | ANKRD50 interactions | 8.65e-04 | 108 | 35 | 3 | int:ANKRD50 | |
| Interaction | FASTK interactions | 9.28e-04 | 26 | 35 | 2 | int:FASTK | |
| Interaction | HDAC6 interactions | 9.37e-04 | 929 | 35 | 7 | int:HDAC6 | |
| Cytoband | 1q25.2 | 2.74e-04 | 31 | 36 | 2 | 1q25.2 | |
| Cytoband | 17q25.3 | 2.88e-03 | 101 | 36 | 2 | 17q25.3 | |
| GeneFamily | EF-hand domain containing|Plakins | 4.31e-05 | 8 | 23 | 2 | 939 | |
| GeneFamily | RNA binding motif containing|Serine and arginine rich splicing factors | 1.01e-04 | 12 | 23 | 2 | 737 | |
| GeneFamily | G-patch domain containing|Minor histocompatibility antigens | 3.52e-04 | 22 | 23 | 2 | 579 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 4.94e-04 | 26 | 23 | 2 | 904 | |
| GeneFamily | PDZ domain containing | 1.58e-02 | 152 | 23 | 2 | 1220 | |
| GeneFamily | EF-hand domain containing | 3.13e-02 | 219 | 23 | 2 | 863 | |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S2 | 1.66e-05 | 115 | 35 | 4 | M7995 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.79e-07 | 194 | 36 | 5 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.56e-07 | 200 | 36 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.56e-07 | 200 | 36 | 5 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.56e-07 | 200 | 36 | 5 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.44e-05 | 184 | 36 | 4 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.44e-05 | 184 | 36 | 4 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 1.47e-05 | 185 | 36 | 4 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.50e-05 | 186 | 36 | 4 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.63e-05 | 190 | 36 | 4 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.67e-05 | 191 | 36 | 4 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 193 | 36 | 4 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 193 | 36 | 4 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 193 | 36 | 4 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-05 | 193 | 36 | 4 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.77e-05 | 194 | 36 | 4 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.77e-05 | 194 | 36 | 4 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 195 | 36 | 4 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 195 | 36 | 4 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 198 | 36 | 4 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.92e-05 | 198 | 36 | 4 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 198 | 36 | 4 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 1.96e-05 | 199 | 36 | 4 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.00e-05 | 200 | 36 | 4 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.00e-05 | 200 | 36 | 4 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 2.00e-05 | 200 | 36 | 4 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.00e-05 | 200 | 36 | 4 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 2.00e-05 | 200 | 36 | 4 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 2.00e-05 | 200 | 36 | 4 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.00e-05 | 200 | 36 | 4 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.00e-05 | 200 | 36 | 4 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 2.00e-05 | 200 | 36 | 4 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.75e-04 | 135 | 36 | 3 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | Adult-Immune-mast_cell|Adult / Lineage, Cell type, age group and donor | 2.94e-04 | 161 | 36 | 3 | 44f5c0256b3ce264a6c7b62740f32dcd45ee052d | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Lymphocytic-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 165 | 36 | 3 | 475905d608fac628960188ae4a18010b8097417e | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-04 | 166 | 36 | 3 | 66026988509e39e41274fa0de738383219e8ff30 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.34e-04 | 168 | 36 | 3 | 6501495b7ad252af330b18011696c43031541018 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.34e-04 | 168 | 36 | 3 | 315ca578c945aeeb77acda2727f3e6db8b43f43e | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 3.45e-04 | 170 | 36 | 3 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor_pre-Lymphocytic-T|bone_marrow / Manually curated celltypes from each tissue | 3.57e-04 | 172 | 36 | 3 | a66402d15853f0c9e3d06394ff9ac08d1da128ff | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.70e-04 | 174 | 36 | 3 | feed99acd868db61f045e666dbfdcaed91ca1488 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 3.70e-04 | 174 | 36 | 3 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-conventional_dendritic_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.76e-04 | 175 | 36 | 3 | c58a1f02d1e559d3638fe1500e960e82a8a7187b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-04 | 177 | 36 | 3 | 8e4005fad50e6f919da175f3b9ae58849dbd60b1 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-04 | 179 | 36 | 3 | 6eb84fe9691ad40127b2d1f1c672428333c8fab4 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.01e-04 | 179 | 36 | 3 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.01e-04 | 179 | 36 | 3 | 7394e77e665bf16d3733df91bb12907be460ab44 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-04 | 179 | 36 | 3 | 2c3abd646d2c8992e8ff76a824eab5beba8ba4c6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.15e-04 | 181 | 36 | 3 | 5bf7aa43f6e6ecce15c95928b91195544d6928c4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.15e-04 | 181 | 36 | 3 | 8e751f5d7cd2d328ec0196d874e8a507e8c4e1a9 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 4.35e-04 | 184 | 36 | 3 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.42e-04 | 185 | 36 | 3 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.42e-04 | 185 | 36 | 3 | b848b63aff4d9dbb9e66a85876d4c7c6dacd0579 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-04 | 185 | 36 | 3 | 53854a9ec87c24c360541c83d86d8fafb303ad58 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-04 | 185 | 36 | 3 | a61fc7a3700a1efcf640bef7680c0443ee148a46 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.42e-04 | 185 | 36 | 3 | 9197f074e769d54031ec41abfc65fcc0c6552c7e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.42e-04 | 185 | 36 | 3 | ce7d62394b09c26ca65b8cdb280afec5e25bbb62 | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 4.49e-04 | 186 | 36 | 3 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.49e-04 | 186 | 36 | 3 | 76535681667c8afb884fa72b6edfee9e1e46335b | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-04 | 187 | 36 | 3 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.56e-04 | 187 | 36 | 3 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.56e-04 | 187 | 36 | 3 | 24c2a3962da364e46e98abeab5f8234376fa26bb | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 4.56e-04 | 187 | 36 | 3 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-04 | 188 | 36 | 3 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-04 | 188 | 36 | 3 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | ASK454-Epithelial-Type_1|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.63e-04 | 188 | 36 | 3 | 13f8ce8f24ac7d7ed87f4ae3b8f4096de29383c2 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 4.70e-04 | 189 | 36 | 3 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.78e-04 | 190 | 36 | 3 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-04 | 191 | 36 | 3 | fd01a206763dfb6d52cca67123571936b4a8e1a0 | |
| ToppCell | Myeloid-Myeloid-B_(Activated_Macrophage)|Myeloid / shred on cell class and cell subclass (v4) | 4.85e-04 | 191 | 36 | 3 | 7bf125249af1e8bb138ed4d999fdd74b03ab2447 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.92e-04 | 192 | 36 | 3 | ef0aba777072429a6ab7dcfcc305673975946580 | |
| ToppCell | droplet-Pancreas-Endocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.92e-04 | 192 | 36 | 3 | 4510aa262da8dcf7c944b3907a51aba5a9397a4e | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 4.92e-04 | 192 | 36 | 3 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.92e-04 | 192 | 36 | 3 | 1304e69c92cef3bd8c82e3c035a7562f5440139a | |
| ToppCell | droplet-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.92e-04 | 192 | 36 | 3 | 0dfd1e9896c34aee0f842f8de5d0e3af62a15f68 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.00e-04 | 193 | 36 | 3 | 3eaa0461618582a1754400624350d269d24e750a | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.00e-04 | 193 | 36 | 3 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.00e-04 | 193 | 36 | 3 | cdc44bf6f5436eb8a2d4720fe011dcb85ccecf87 | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-04 | 194 | 36 | 3 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-04 | 194 | 36 | 3 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.08e-04 | 194 | 36 | 3 | 43eb677a76634bb9a48a40e0d607c4936ae64bcc | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-04 | 194 | 36 | 3 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-04 | 194 | 36 | 3 | 92b39a935e8c577eb1123d706d168fa13cf3344c | |
| ToppCell | BL-critical-LOC-Epithelial-Basal|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.08e-04 | 194 | 36 | 3 | 2932f704656ca368565ec12f3452af3b18e8df12 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-04 | 195 | 36 | 3 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 5.23e-04 | 196 | 36 | 3 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 5.31e-04 | 197 | 36 | 3 | eb7610c9496a95a5fd866e16abcbc39b83abe617 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-sinusoidal_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.31e-04 | 197 | 36 | 3 | f1080d93acf1a4756d2f2c8cabd1fb50bc7bcd09 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.31e-04 | 197 | 36 | 3 | b2f4d7c301c0b24003374923b31d6d058e40b213 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.31e-04 | 197 | 36 | 3 | 4e58bbf3ecb30b4c8199adcc04d2eb134d90de56 | |
| ToppCell | Healthy/Control-cDC|World / Disease group and Cell class | 5.31e-04 | 197 | 36 | 3 | 4497d4073f4d3e74de907325fba9eb4af5766bf4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.31e-04 | 197 | 36 | 3 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | Healthy_donor-cDC|World / disease group, cell group and cell class (v2) | 5.31e-04 | 197 | 36 | 3 | a545fe3a80cd721bf01115bbb645753840ec9f40 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-tip_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.31e-04 | 197 | 36 | 3 | b212ff28ca2d1fea4140f186ab90941bdca21249 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.31e-04 | 197 | 36 | 3 | b7aff83c27606d87565382a768119a863fe1c294 | |
| ToppCell | ASK452-Epithelial-Type_1|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.31e-04 | 197 | 36 | 3 | dc0a6dca4af6b216357b06f67203274f8b2a8bb0 | |
| ToppCell | AT1-AT2_cells|World / lung cells shred on cell class, cell subclass, sample id | 5.39e-04 | 198 | 36 | 3 | a5b3617ea2ed4bffba59edcf6284799c2b3bbb29 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.39e-04 | 198 | 36 | 3 | 36c97eb71b89bac01cabd6a8b728e5a20e52d2a3 | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.39e-04 | 198 | 36 | 3 | 7063d74d79f53d5c59c853a2575f9d3ef12f19ea | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.39e-04 | 198 | 36 | 3 | 1e83bec16dcd60460422625f89952ff506d6be51 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.39e-04 | 198 | 36 | 3 | 2630a7a6e56febe5c0b0bde70dd7292fa1650c47 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.57e-04 | 50 | 23 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Drug | Hycanthone [3105-97-3]; Down 200; 11.2uM; HL60; HG-U133A | 9.42e-06 | 187 | 35 | 5 | 1614_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 1.10e-05 | 193 | 35 | 5 | 2721_DN | |
| Drug | Naloxone hydrochloride [357-08-4]; Down 200; 11uM; PC3; HG-U133A | 1.13e-05 | 194 | 35 | 5 | 1924_DN | |
| Drug | Erythromycin [114-07-8]; Down 200; 5.4uM; HL60; HG-U133A | 1.24e-05 | 198 | 35 | 5 | 2010_DN | |
| Disease | brain measurement, neuroimaging measurement | 3.96e-03 | 550 | 35 | 4 | EFO_0004346, EFO_0004464 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RSRSRSRSPRPRGDS | 1116 | P21860 | |
| RDESSRSPARRGPGR | 1471 | Q9P281 | |
| SRSLGRRSRSPRPSK | 286 | Q9NXE8 | |
| RPPSSRRPRTRRSSS | 1111 | Q8TF62 | |
| SRSRRRSRVGSPRSP | 366 | O14525 | |
| RGSRSRSRSRSPGRP | 76 | Q14739 | |
| PRPRRRSRRASGLST | 11 | Q7Z628 | |
| STPSRRGSRRGRATP | 6 | P33991 | |
| RSPTRRRDGSPSRRR | 1386 | Q96QZ7 | |
| FRPRGRRSRPSSRGA | 7401 | Q03001 | |
| RRSRPSSRGASPNRS | 7406 | Q03001 | |
| GSRPRPSPRSRSRSG | 206 | A0A1B0GVG4 | |
| RSRSGPSGGCRRPAR | 216 | A0A1B0GVG4 | |
| RPRARGASRRTSAGP | 726 | O14511 | |
| RSSSRESRGRGGRTP | 6 | Q9NP85 | |
| PFRSRGRRSKPSSRA | 3341 | O94854 | |
| RGPRRYRTPSRSRSR | 336 | Q13427 | |
| RGRSRSRERRTPPGR | 601 | Q13427 | |
| GRRRDSASPPGRSRS | 6 | Q9UP83 | |
| PRRSSPGRGRSPRRG | 496 | Q5TZA2 | |
| SPGRRRRSRSRSPTP | 806 | Q8IWX8 | |
| HSRSPRRGRSRSRSP | 101 | Q9NYF8 | |
| SPRRRKGGLRRTRPT | 101 | Q9NR34 | |
| PRGRLRSRDSSCGRP | 71 | Q9UL51 | |
| RRTGTPSDPRRRLRS | 306 | O60716 | |
| SRSRSRERPSAPRGI | 76 | Q8N5F7 | |
| SPATRGRSRSRTPAR | 566 | Q9UQ35 | |
| RTPARRGRSRSRTPA | 576 | Q9UQ35 | |
| SRTPARRGRSRSRTP | 606 | Q9UQ35 | |
| TPARRGRSRSRTPAR | 651 | Q9UQ35 | |
| RTPARRGRSRSRTPA | 661 | Q9UQ35 | |
| PARRGRSRSRTPRRG | 686 | Q9UQ35 | |
| SSLPRSRRPSRGVRA | 526 | Q9BWN1 | |
| RSPLSPRSRRGSARE | 31 | Q9NXX6 | |
| RSPRRRHRSRSRGPS | 126 | Q9BRL6 | |
| SRRRRRSSSGSPPSP | 16 | Q5M9Q1 | |
| GRTPGRRGSRSSKRS | 121 | B3KS81 | |
| RKAPRPRGRRTRSSG | 106 | Q8TBP0 | |
| PSSSCGPRSRRRARD | 146 | Q8N5L8 | |
| GRSHDRPPRRSRSRS | 301 | Q07157 | |
| GPRSPSYGRSRSRSR | 196 | Q07955 | |
| GTRRPGSRGSDSRRP | 76 | P22735 | |
| SRRSRTPSRRSRTPS | 1961 | P18583 | |
| TPSRRSRTPSRRSRT | 1966 | P18583 | |
| SRTPSRRSRTPSRRS | 1971 | P18583 | |
| PSRRSRTPSRRSRTP | 1981 | P18583 | |
| RSPRGRSRGRPSTGG | 336 | P28698 |